Drug
Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation: highest development phase Phase 1/2, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplantation NCT03878199 | Phase 1/2 | Essential Thrombocythemia |
Latest
No recent events.
Follow Allogeneic Hematopoietic Stem Cell Transplantation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.